Rheumatoid arthritis (also known as RA) can be a very painful condition. For many patients, RA pain is severe enough to impact their everyday lives. Below, we will go over the most common RA symptoms. Diagnosing and treating RA early is the best way to slow this disease’s progress. Therefore, it’s important to know which symptoms to look for.
What is Rheumatoid Arthritis?
Rheumatoid Arthritis is an autoimmune disease that causes painful swelling and inflammation. Autoimmune diseases are caused by a person’s immune system attacking healthy parts of the body instead of unhealthy infections. This can cause chronic pain, swelling, and other symptoms. For RA patients, this pain is usually in and around a person’s joints. However, RA can also affect other parts of the body.
Key Symptoms and Warning Signs
The main RA warning sign is pain or stiffness in a person’s joints. Other symptoms include changes to a joint’s appearance, problems walking, mobility issues, and general feelings of malaise. Because many RA symptoms are very general, it can be tough to diagnose this disease. If you have these symptoms, it is important to bring your concerns to a doctor.
Current RA Treatments
While there is no cure for RA, there are treatment options. Most RA patients will take medication to manage their disease. These medications can help to reduce pain and also limit inflammation. Some RA patients might also need occupational therapy or surgery.
How a Clinical Trial Can Help Your Symptoms
If you are struggling with RA, then traditional treatments might not be enough. Some patients try numerous medications and still deal with painful symptoms. Clinical trials might be the answer for these patients. Clinical trials allow you to try the latest treatments with doctor supervision. All medications, lab work, exams, and doctor’s appointments are covered free of charge. Patients might also be compensated.
If you are an RA patient over the age of 18, you might qualify for a trial at DM Clinical Research. To learn more about our RA study, call the study’s direct line at 281-401-9803.